These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
812 related items for PubMed ID: 34487251
1. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients. Zahid N, Martins RS, Zahid W, Khalid W, Azam I, Bhamani SS, Asad N, Ahmad K, Jabbar AA, Shamim MS, Khan RJ, Javed G, Bari E, Enam SA. J Patient Rep Outcomes; 2021 Sep 06; 5(1):79. PubMed ID: 34487251 [Abstract] [Full Text] [Related]
2. Psychometric properties of the Urdu version of the EORTC QLQ-H&N35 (European organization for research and treatment of cancer head and neck module) quality of life tool. Zahid N, Martins RS, Zahid W, Azam I, Ikram M, Hassan A, Bhamani SS, Jabbar AA, Asad N, Akhtar S, Siddiqui MI, Awan MS, Ahmad K. BMC Psychol; 2022 Aug 07; 10(1):194. PubMed ID: 35934706 [Abstract] [Full Text] [Related]
5. Evaluation of health-related quality of life in Lithuanian brain tumor patients using the EORTC brain cancer module. Bunevičius A, Tamašauskas Š, Tamašauskas A, Deltuva V. Medicina (Kaunas); 2012 Aug 07; 48(11):588-94. PubMed ID: 23455894 [Abstract] [Full Text] [Related]
7. Introduction of Questionnaires for Quality of Life of Patients with Malignant Tumors of the Central Nervous System into Neurosurgical Practice in the Republic of Kazakhstan. Akshulakov S, Aldiyarova N, Ryskeldiyev N, Akhmetzhanova Z, Gaitova K, Auezova R, Doskaliyev A, Kerimbayev T. Asian Pac J Cancer Prev; 2016 Aug 07; 17(2):873-6. PubMed ID: 26925695 [Abstract] [Full Text] [Related]
8. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia. Araya LT, Gebretekle GB, Gebremariam GT, Fenta TG. Health Qual Life Outcomes; 2019 Jan 14; 17(1):13. PubMed ID: 30642359 [Abstract] [Full Text] [Related]
9. Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30. Chiu L, Chiu N, Zeng L, Zhang L, Popovic M, Chow R, Lam H, Poon M, Chow E. Expert Rev Pharmacoecon Outcomes Res; 2012 Dec 14; 12(6):831-7. PubMed ID: 23252363 [Abstract] [Full Text] [Related]
10. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30. Guzelant A, Goksel T, Ozkok S, Tasbakan S, Aysan T, Bottomley A. Eur J Cancer Care (Engl); 2004 May 14; 13(2):135-44. PubMed ID: 15115469 [Abstract] [Full Text] [Related]
13. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Taphoorn MJ, Claassens L, Aaronson NK, Coens C, Mauer M, Osoba D, Stupp R, Mirimanoff RO, van den Bent MJ, Bottomley A, EORTC Quality of Life Group, and Brain Cancer, NCIC and Radiotherapy Groups. Eur J Cancer; 2010 Apr 14; 46(6):1033-40. PubMed ID: 20181476 [Abstract] [Full Text] [Related]
14. The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review. Leung A, Lien K, Zeng L, Nguyen J, Caissie A, Culleton S, Holden L, Chow E. Expert Rev Pharmacoecon Outcomes Res; 2011 Dec 14; 11(6):693-700. PubMed ID: 22098285 [Abstract] [Full Text] [Related]
15. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients. Cankurtaran ES, Ozalp E, Soygur H, Ozer S, Akbiyik DI, Bottomley A. Eur J Cancer Care (Engl); 2008 Jan 14; 17(1):98-104. PubMed ID: 18181898 [Abstract] [Full Text] [Related]
17. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress. Browall M, Kenne Sarenmalm E, Nasic S, Wengström Y, Gaston-Johansson F. J Pain Symptom Manage; 2013 Jul 14; 46(1):131-41. PubMed ID: 23195392 [Abstract] [Full Text] [Related]
18. Comparison of the EORTC QLQ-BN20 and the FACT-Br quality of life questionnaires for patients with primary brain cancers: a literature review. Chow R, Lao N, Popovic M, Chow E, Cella D, Beaumont J, Lam H, Pulenzas N, Bedard G, Wong E, DeAngelis C, Bottomley A. Support Care Cancer; 2014 Sep 14; 22(9):2593-8. PubMed ID: 25015058 [Abstract] [Full Text] [Related]
20. Cross-cultural application of the Korean version of the EORTC QLQ-ELD14 questionnaire for elderly patients with cancer. Goo AJ, Shin DW, Yang HK, Park JH, Kim SY, Shin JY, Kim YA, Kim C, Hong NS, Min YJ, Park K. J Geriatr Oncol; 2017 Jul 14; 8(4):271-276. PubMed ID: 28377101 [Abstract] [Full Text] [Related] Page: [Next] [New Search]